• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

health

  1. Authentic Leadership in Health Care

    This article is written as part of the MHA542 Leading with authenticity in health care course through the University of Phoenix Master of Health Administration (MHA) Program. At an extremely basic level, I believe leadership is all about people. It encompasses how one behaves and the...
  2. Amgen sees sales fall in some of its biggest established products

    https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing its product portfolio, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.
  3. Amgen sees sales fall in some of its biggest established products

    https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing their product portfolios, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.
  4. JNJ's AIDS vaccine could soon be a reality

    At an AIDS conference in Paris on July 24, 2017, Johnson&Johnson announced updates on its developmental AIDS drug. And guess what, it's good news!